BY DEEP INTRAMUSCULAR INJECTION, OR BY INTRAVENOUS INJECTION OVER AT LEAST 2 - 4 MINUTES, OR BY INTRAVENOUS INFUSION, 1 G DAILY; 2 - 4 G DAILY IN SEVERE INFECTIONS; INTRAMUSCULAR DOSES OVER 1 G DIVIDED BETWEEN MORE THAN ONE SITE; SINGLE INTRAVENOUS DOSES ABOVE 1 G BY INTRAVENOUS INFUSION ONLY
NEONATE BY INTRAVENOUS INFUSION OVER 60 MINUTES, 20 - 50 MG/KG DAILY (MAX. 50 MG/KG DAILY) INFANT AND CHILD UNDER 50 KG, BY DEEP INTRAMUSCULAR INJECTION, OR BY INTRAVENOUS INJECTION OVER 2 - 4 MINUTES, OR BY INTRAVENOUS INFUSION, 20 - 50 MG/KG DAILY; UP TO 80 MG/KG DAILY IN SEVERE INFECTIONS; DOSES OF 50 MG/KG AND OVER BY INTRAVENOUS INFUSION ONLY; 50 KG AND OVER, ADULT DOSE
ENDOCARDITIS CAUSED BY HAEMOPHILUS, ACTINOBACILLUS, CARDIOBACTERIUM, EIKENELLA, AND KINGELLA SPECIES (`HACEK ORGANISMS') (IN COMBINATION WITH ANOTHER ANTIBACTERIAL, SEE TABLE 1, SECTION 5.1; [UNLICENSED INDICATION]), BY INTRAVENOUS INFUSION, 2 - 4 G DAILY
UNCOMPLICATED GONORRHOEA, BY DEEP INTRAMUSCULAR INJECTION, 250 MG AS A SINGLE DOSE
SURGICAL PROPHYLAXIS, BY DEEP INTRAMUSCULAR INJECTION OR BY INTRAVENOUS INJECTION OVER AT LEAST 2 - 4 MINUTES, 1 G AT INDUCTION; COLORECTAL SURGERY, BY DEEP INTRAMUSCULAR INJECTION OR BY INTRAVENOUS INFUSION, 2 G AT INDUCTION; INTRAMUSCULAR DOSES OVER 1 G DIVIDED BETWEEN MORE THAN ONE SITE